Kim Westerdijk (K Westerdijk)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 9

Top Topics

Metastatic Renal Cell Carcinoma

Intensive Care Unit

Chronic Myeloid Leukemia

Top Venues

Cancer chemotherapy and pharmacology

British journal of clinical pharmacology

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Kim Westerdijk, S D Krens, N Steeghs, W T A van der Graaf, E T T L Tjwa, H Westdorp, I M E Desar, N P van Erp
Real-world data on the management of pazopanib-induced liver toxicity in routine care of renal cell cancer and soft tissue sarcoma patients. Cancer chemotherapy and pharmacology 93 (4) (2023)
Kim Westerdijk, S D Krens, N Steeghs, W T A van der Graaf, E T T L Tjwa, H Westdorp, I M E Desar, N P van Erp
Real-world data on the management of pazopanib-induced liver toxicity in routine care of renal cell cancer and soft tissue sarcoma patients. Cancer chemotherapy and pharmacology 93 (4) (2023)
Kim Westerdijk, S D Krens, N Steeghs, W T A van der Graaf, E T T L Tjwa, H Westdorp, I M E Desar, N P van Erp
Real-world data on the management of pazopanib-induced liver toxicity in routine care of renal cell cancer and soft tissue sarcoma patients. Cancer chemotherapy and pharmacology (2023)
Kim Westerdijk, Neeltje Steeghs, Casper S J Tacke, Winette T A van der Graaf, Nielka P van Erp, Gerard van Oortmerssen, Rosella P M G Hermens, Ingrid M E Desar, null null
Therapeutic drug monitoring to personalize dosing of imatinib, sunitinib, and pazopanib: A mixed methods study on barriers and facilitators. Cancer medicine (2023)
Kim Westerdijk, S D Krens, N Steeghs, W T A van der Graaf, E T T L Tjwa, H Westdorp, I M E Desar, N P van Erp
Real-world data on the management of pazopanib-induced liver toxicity in routine care of renal cell cancer and soft tissue sarcoma patients. Cancer chemotherapy and pharmacology 93 (4) (2023)
Kim Westerdijk, S D Krens, N Steeghs, W T A van der Graaf, E T T L Tjwa, H Westdorp, I M E Desar, N P van Erp
Real-world data on the management of pazopanib-induced liver toxicity in routine care of renal cell cancer and soft tissue sarcoma patients. Cancer chemotherapy and pharmacology 93 (4) (2023)
Kim Westerdijk, Ingrid M E Desar, Neeltje Steeghs, Winette T A van der Graaf, Nielka P van Erp, null null
Imatinib, sunitinib and pazopanib: From flat-fixed dosing towards a pharmacokinetically guided personalized dose. British journal of clinical pharmacology 86 (2) (2020)
Kim Westerdijk, Stefanie D Krens, Winette T A van der Graaf, Sasja F Mulder, Carla M L van Herpen, Tineke Smilde, Nielka P van Erp, Ingrid M E Desar
The relationship between sunitinib exposure and both efficacy and toxicity in real-world patients with renal cell carcinoma and gastrointestinal stromal tumour. British journal of clinical pharmacology 87 (2) (2020)
Kim Westerdijk, Koen S Simons, Marissa Zegers, Peter C Wever, Peter Pickkers, Cornelis P C de Jager
The value of the neutrophil-lymphocyte count ratio in the diagnosis of sepsis in patients admitted to the Intensive Care Unit: A retrospective cohort study. PloS one 14 (2) (2019)